TSE:NVLN Novelion Therapeutics Inc, (NVLN) Stock Price, News & Analysis → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free NVLN Stock Alerts C$13.30 -0.35 (-2.56%) (As of 05/3/2017) Add Compare Share Share Today's RangeC$13.12▼C$13.6750-Day RangeC$13.30▼C$13.3052-Week RangeC$10.68▼C$16.35Volume3,639 shsAverage Volume3,220 shsMarket CapitalizationC$251.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Novelion Therapeutics Inc, alerts: Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. About Novelion Therapeutics Inc,Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.Read More NVLN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NVLN Stock News HeadlinesApril 21, 2024 | finance.yahoo.comVoyager Therapeutics, Inc. (VYGR)April 18, 2024 | investing.comVivos Therapeutics Inc (VVOS)May 7, 2024 | Crypto 101 Media (Ad)Elon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.March 24, 2024 | morningstar.comCentury Therapeutics Inc IPSCFebruary 14, 2024 | wsj.comCymaBay Therapeutics Inc.February 6, 2024 | investing.comAclaris Therapeutics Inc (ACRS)January 3, 2024 | investing.comHighTide Therapeutics Inc (2511)December 30, 2023 | investing.comIntensity Therapeutics Inc (INTS)May 7, 2024 | Crypto 101 Media (Ad)Elon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.December 17, 2023 | morningstar.comLeap Therapeutics Inc LPTXNovember 14, 2023 | morningstar.comAileron Therapeutics Inc ALRNNovember 11, 2023 | morningstar.comAtossa Therapeutics Inc ATOSNovember 1, 2023 | morningstar.comBeam Therapeutics Inc BEAMNovember 1, 2023 | morningstar.comAprea Therapeutics Inc APRENovember 1, 2023 | morningstar.comCelldex Therapeutics Inc CLDXOctober 31, 2023 | morningstar.comCARISMA Therapeutics Inc CARMSeptember 29, 2023 | finance.yahoo.comIs Viking Therapeutics, Inc. a Buy?August 26, 2023 | seekingalpha.comIMUN Immune Therapeutics, Inc.August 24, 2023 | seekingalpha.comELVN Enliven Therapeutics, Inc.May 10, 2023 | morningstar.comSigilon Therapeutics Inc Ordinary SharesApril 25, 2023 | finance.yahoo.comSarepta Therapeutics, Inc. (SRPT)April 20, 2023 | morningstar.comNurix Therapeutics Inc Ordinary SharesApril 20, 2023 | seekingalpha.comZVSA ZyVersa Therapeutics, Inc.March 26, 2023 | finanznachrichten.deDefence Therapeutics Inc.: Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 MillionFebruary 26, 2023 | benzinga.comWindtree Therapeutics Stock (NASDAQ:WINT), Quotes and News SummaryJanuary 28, 2023 | seekingalpha.comFDMT 4D Molecular Therapeutics, Inc.January 27, 2023 | seekingalpha.comAVTE Aerovate Therapeutics, Inc.See More Headlines Receive NVLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novelion Therapeutics Inc, and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolTSE:NVLN Previous SymbolTSE:QLT CUSIPN/A CIKN/A Webwww.novelion.com Phone+1-604-7077000FaxN/AEmployees109Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares18,932,000Free FloatN/AMarket CapC$251.80 million OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key CompetitorsImvescor Restaurant GroupTSE:IRGRedknee SolutionsTSE:RKNHalogen SoftwareTSE:HGNTIO NetworksCVE:TNCAMI.TOTSE:AMIView All Competitors NVLN Stock Analysis - Frequently Asked Questions How have NVLN shares performed in 2024? Novelion Therapeutics Inc,'s stock was trading at C$13.30 at the beginning of 2024. Since then, NVLN stock has increased by 0.0% and is now trading at C$13.30. View the best growth stocks for 2024 here. What other stocks do shareholders of Novelion Therapeutics Inc, own? Based on aggregate information from My MarketBeat watchlists, some companies that other Novelion Therapeutics Inc, investors own include Alnylam Pharmaceuticals (ALNY), NXP Semiconductors (NXPI), Whole Foods Market (WFM), InvenSense (INVN), OPKO Health (OPK), Vitamin Shoppe (VSI), Aurora Cannabis (ACB), ABGBY (ABGBY), Gilead Sciences (GILD) and 3D Systems (DDD). How do I buy shares of Novelion Therapeutics Inc,? Shares of NVLN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NVLN) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novelion Therapeutics Inc, Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
